S tem cells from human exfoliated deciduous teeth (SHED) reside within the perivascular niche of the dental pulp. They are thought to originate from the cranial neural crest, and express early markers for both mesenchymal and neuroectodermal stem cells. 1, 2 We previously showed that SHED transplantation into the completely transected rat spinal cord results in remarkable functional recovery of hindlimb locomotion. 2 However, whether engrafted SHED or the paracrine factors derived from them can offer therapeutic benefits in other neurological disease settings is still largely unknown. In this study, we investigated the therapeutic benefits of SHED on mouse neonatal hypoxia-ischemia (HI).
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Figure 1.
Neurological outcomes and survival rate after HI. A, Experimental protocol. Mice underwent HI insult at P5, and then received cell transplantation (Cell) or CM injection (CM) at P6. In the analyses of cell transplantation's effects on functional recovery and brain damage, the phosphate buffered saline-, Fb-, and SHED-treated groups received daily administrations of cyclosporin A (CsA). The cytokine assay and brain damage evaluation were performed at P7 and P8, respectively. Neurological recovery was examined at 4, 6, and 8 weeks. B, Survival curve (SHED n =14; Fb n=12; PBS n = 18; SHED-CM n = 16; Fb-CM n = 16; DMEM n = 16; Sham n = 5). C, Foot-fault test (SHED n=12; Fb n=9; PBS n = 9; SHED-CM n = 15; Fb-CM n = 10; DMEM n = 13; Sham n = 5). D, Statistic data. Values are means±SEM, *P< 0.05, ***P< 0.001.
Figure 2.
Histological evaluation. A, Representative HE-stained coronal brain sections. 
Results
The HI mice that underwent SHED transplantation exhibited significant neurological recovery compared with the fibroblasts-and phosphate buffered saline-treated groups ( Figure 1C ). The SHED-transplanted group also displayed better survival over time ( Figure 1B ). Histological examination revealed that the tissue loss, number of apoptotic cells, and neuropathological score in the SHED-transplanted group were significantly lower than in the other experimental groups (Figure 2A and B ). Cell-type analysis showed that the apoptosis of neurons in the cortex, corpus callosum, and hippocampus and of oligodendrocytes in the corpus callosum was significantly reduced in the SHED-transplanted group (onlineonly Supplemental Figure 2 ). The expression levels of proinflammatory cytokines interleukin-1β and tumor necrosis factor-α were upregulated in the phosphate buffered saline-and fibroblasts-transplanted groups 24 hours after HI, but those of anti-inflammatory cytokines interleukin-4 and interleukin-10 were downregulated. Notably, engrafted SHED significantly suppressed the expression of proinflammatory cytokines, whereas strongly upregulating anti-inflammatory cytokines ( Figure 3 ).
Eight weeks after transplantation, little or no SHED had differentiated into neurons, oligodendrocytes, or astrocytes (online-only Supplemental Figure 3 ). Taken together, these results suggested that SHED promoted recovery after HI by paracrine mechanisms. In support of this idea, we found that mice receiving a 2-μL injection of SHED-CM in the HI-injured brain exhibited significant or better recovery in neurological function ( Figure 1C ), survival rate ( Figure 1B) , and neuropathological score ( Figure 2C ) than those receiving fibroblasts-CM or cell-culture medium (Dulbecco's modification of Eagle's medium) alone.
Discussion
Here we demonstrated that the transplantation of SHED into the HI-injured mouse brain improved the neurological outcome and survival rate. The engrafted SHED shifted the HI-induced proinflammatory state to an anti-inflammatory one and inhibited apoptosis and tissue loss. Importantly, mice receiving an injection of 2 µL SHED-CM 24 hours after HI exhibited significant recovery as assessed by both neurological and pathological examinations. These results suggest that most of the SHED-mediated therapeutic benefits were elicited by paracrine mechanisms. It was difficult to compare the level of therapeutic benefits between engrafted SHED and SHED-CM, because in the SHED experiments, the administration of cyclosporin A, which protects engrafted cells from the xenogeneic host immune response, significantly suppressed the HI-induced inflammatory response and apoptosis 6 (online-only Supplemental Figure 4 ). Furthermore, cell transplantation may have an advantage in providing a prolonged delivery of paracrine factors, compared with the transient delivery by the CM treatment.
Previous reports indicate that the engraftment of various types of transplanted stem cells is a promising regenerative therapy for HI. 7 However, for clinical use, mesenchymal stem cells must be expanded by a reliable cell-culture system that produces sufficient cell numbers to elicit clinical benefits, while also meeting safety requirements. These severe restrictions may impede the progress of regenerative therapy for HI. Our data suggest that the administration of SHED-CM provides a portion of the therapeutic benefit of SHED 
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Supplemental Methods
Cell Culture and CM Preparation
Human dental pulp tissues were obtained from clinically extracted, healthy deciduous teeth from three patients. The ethics committee of Nagoya University approved our experimental protocols. The SHED were isolated and cultured, and the CM was prepared as previously described 1 . In brief, 80% confluent cells were washed three times with PBS followed by two washes with DMEM. The cells were then incubated in DMEM for 48 hr at 37°C in 5% CO 2 . The CMs were collected, and cell debris was removed by centrifugation. Fb (SF-TY, JCRB0075) were purchased from Health Science Research Resources Bank in Japan.
Flow cytometry analysis showed that the SHED expressed a set of mesenchymal stem cell (MSC) markers (i.e., CD90, CD73, and CD105), but not endothelial/ hematopoietic markers (i.e., CD34, CD45, CD11b/c, and HLA-DR) 1 . Like human BMSCs, SHED exhibited adipogenic, chondrogenic, and osteogenic differentiation as described previously 2, 3 .
HI Induction
All animal-related procedures were approved by the Laboratory Animal Care and Use Committee of Nagoya City University and were conducted in accordance with the guidelines of the NIH. Wild-type ICR mice were purchased from SLC (Shizuoka, Japan). HI brain injury was induced in postnatal day 5 (P5) mice as described 4 . The pups were anesthetized with 2% isoflurane in a mixture of N2O and O2 (2:1), and the right common carotid artery was cauterized. After a 30-minute recovery period, the pups were placed in a plastic chamber containing a humidified atmosphere of 8% O2 and 92% N2, and submerged in a 37.5°C water bath to maintain normothermia. After 20 minutes of hypoxia, the pups were returned to their dams.
Cell Transplantation and CM Injection
For cell transplantation, the cells were infused into the ipsilateral hemisphere at 2.0 mm anterior and 2.0 mm lateral to bregma, and 2.0 mm deep to the dural surface, using a glass needle and a Kopf microstereotaxic injection system. Approximately 2×105 cells in 2 µl PBS were injected. The animals receiving cell transplantation were given daily injections of cyclosporin A (Novartis, Nurnberg, Germany, 10 mg/kg, i.p.) throughout the experimental period, except when the animals were used for cytokine expression analysis. For CM injection, SHED-CM, Fb-CM, or DMEM was injected into the damaged brain 24 hours after HI at the position described for cell transplantation. The CM-injected mice were maintained without cyclosporine A.
Histology and Immunohistochemistry
Brains were perfusion-fixed with 4% paraformaldehyde and postfixed in the same Various brain areas were outlined manually using ImageJ software.
Brain Damage Assessment and Apoptosis Quantification
Tissue loss and infarct area were examined by staining with hematoxylin and eosin (HE). The percent volume loss in the ipsilateral versus contralateral hemisphere was determined for each animal as previously described 5, 6 . Brain injury was evaluated using a neuropathological scoring system as described previously, by an observer blinded to the animal group 7 . The level of apoptosis was analyzed by staining with anti-caspase-3 alone or together with anti-GFAP, NeuN, or Olig2. The apoptotic cell density was calculated from the total caspase-3-positive cell numbers in a counted area.
Neurological Evaluation
To evaluate neurological motor function, a foot-fault test was performed in 4-, 6-, and 8-week-old HI mice, as described previously 4 . Mice were placed on a hexagonal grid (45×55 cm, 20-cm above the floor). During locomotion, the number of foot faults made by the ipsilateral and contralateral limbs was counted. Each test consisted of 2 trials lasting 5 minutes; trials were performed on consecutive days.
RNA Isolation and RT-PCR
Total RNA isolation, RT reactions, and quantitative PCR were carried out as described 1 .
As an internal control, GAPDH cDNA was amplified. Primer sequences are shown in Supplemental Table 1 .
Statistical Analyses
Data are expressed as means ± SEM. Survival data were expressed by applying the 
